삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

산부인과 최철훈 교수

진료분야
난소암, 자궁경부암, 자궁내막암
진료일정 12 月
날짜
일
01
월
02
화
03
수
04
목
05
금
06
토
07
일
08
월
09
화
10
수
11
목
12
금
13
토
14
일
15
월
16
화
17
수
18
목
19
금
20
토
21
일
22
월
23
화
24
수
25
목
26
금
27
토
28
일
29
월
30
화
31
오전
오후
진료일정 01 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2011.08 고려대학교 의과대학원 의학과 산부인과학 박사
2007.08 성균관대학교 의과대학원 의학과 산부인과학 석사
1997.02 서울대학교 의과대학 의학과 의학사

경력

경력
2022.04 ~현재 삼성서울병원 산부인과 교수
2016.03 ~ 2022.03 삼성서울병원 산부인과 부교수
2012.03 ~ 2016.03 삼성서울병원 산부인과 조교수
2014.05 ~ 2015.07 미국국립암연구소, 방문연구원
2008.03 ~ 2012.02 삼성서울병원 산부인과 임상조교수
2007.03 ~ 2008.02 삼성서울병원 산부인과 임상전임강사
2005.03 ~ 2007.02 삼성서울병원 산부인과 임상강사
2005.03 산부인과 전문의 자격 취득
2001.05 ~ 2005.02 삼성서울병원 산부인과 전공의
1998.04 ~ 2001.04 전북장수의료원 공중보건의 복무
1997.03 ~ 1998.02 서울대학교병원 인턴과정 수료

수상이력

수상이력
2012.10 최우수구연상, 대한산부인과학회
2012.04 최우수포스터상, 일본산부인과학회
2011.10 최우수포스터상, 산부인과내시경학회
2010.05 최우수포스터상, 국제부인내시경학회
2007.03 젊은의학자상, 대만산부인과학회
2006.09 젊은과학자상, 대한산부인과학회
2002.02 올해의 전공의상
논문
  • INT J GYNECOL CANCER 2024 10.1136/ijgc-2024-005919 GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator's choice of treatment in patients with recurrent low grade serous ovarian cancer Grisham, R; Monk, BJ; Van Nieuwenhuysen, E; Moore, KN; Fabbro, M; O'Malley, DM; Oaknin, A; Thaker, P; Oza, AM; Colombo, N; Gershenson, D; Aghajanian, CA; Choi, CH; Lee, YC; Mirza, MR; Coleman, RL; Cobb, L; Harter, P; Lustgarten, S; Youssoufian, H; Banerjee, S
    View PubMed
  • CANCERS 2024 10.3390/cancers16193422 From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps Min, KJ; Kim, NK; Song, JY; Choi, MC; Lee, SW; Lee, KH; Kim, MK; Kang, SK; Choi, CH; Lee, JW; Lee, EJ; Eom, KY; Kim, SW; Cho, HBY; Lee, SJ; Lim, MC; Bae, J; Yoo, CW; Kim, K; Kim, DY; Lee, CL; Ryu, SY; Jeon, S; Kim, JW; Nam, BH; Kang, SB; Kim, KT; Nam, JH; Kim, BG; Kim, YM; Kim, JH
    View PubMed
  • INT J GYNECOL PATHOL 2024 10.1097/PGP.0000000000001007 Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern Bae, BK; Bae, H; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Kim, HS; Park, W
    View PubMed
  • LANCET ONCOL 2024 10.1016/S1470-2045(24)00334-6 Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial Colombo, N; Biagioli, E; Harano, K; Galli, F; Hudson, E; Antill, Y; Choi, CH; Rabaglio, M; Marmé, F; Marth, C; Parma, G; Fariñas-Madrid, L; Nishio, S; Allan, K; Lee, YC; Piovano, E; Pardo, B; Nakagawa, S; Mcqueen, J; Zamagni, C; Manso, L; Takehara, K; Tasca, G; Ferrero, A; Tognon, G; Lissoni, AA; Petrella, M; Laudani, ME; Rulli, E; Uggeri, S; Ginesta, MPB
    View PubMed
  • GLAND SURG 2024 10.21037/gs-23-533 Feasibility of articulating laparoscopic instrument use in laparoscopic adnexectomy: a multicenter prospective observational study Seo, JH; Choi, CH; Lee, YY
    View PubMed
  • FUTURE ONCOL 2024 10.1080/14796694.2024.2357533 OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer Park, J; Cho, HW; Lim, MC; Choi, CH; Lee, JY
    View PubMed
  • INT J GYNECOL OBSTET 2024 10.1002/ijgo.15533 Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study Shim, SH; Yang, EJ; Jang, EB; Lee, S; Kim, HS; Shin, YK; Lee, SW; Chang, CS; Song, H; Lee, SJ; Kim, J; Chang, SJ; Lim, MC; Choi, CH
    View PubMed
  • GYNECOL ONCOL 2024 10.1016/j.ygyno.2024.03.017 Treatment outcomes according to various progestin treatment strategies in patients with atypical hyperplasia/endometrial intraepithelial neoplasia - Multicenter retrospective study (KGOG2033) Kim, NK; Choi, CH; Seong, SJ; Lee, JM; Lee, BHY; Kim, K
    View PubMed
  • GYNECOL ONCOL 2024 10.1016/j.ygyno.2023.12.029 Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial Kim, SI; Joung, JG; Kim, YN; Park, J; Park, E; Kim, JW; Lee, SY; Lee, JB; Kim, S; Choi, CH; Kim, HS; Lim, J; Chung, J; Kim, BG; Lee, JY
    View PubMed
  • FRONT IMMUNOL 2024 10.3389/fimmu.2024.1371353 Efficacy and safety of BVAC-C in HPV type 16-or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study Choi, CH; Lee, JW; Bae, DS; Kang, ES; Cho, DC; Kim, YM; Kim, K; Kim, JW; Kim, HS; Kim, YT; Lee, JY; Lim, MC; Oh, T; Song, B; Jeon, I; Park, M; Kim, WH; Kang, CY; Kim, BG
    View PubMed
  • FRONT GENET 2024 10.3389/fgene.2024.1342021 Comparison of RNA-Seq and microarray in the prediction of protein expression and survival prediction Kim, WJ; Choi, BR; Noh, JJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2024 10.3802/jgo.2024.35.e43 Clinical guidelines for ovarian cancer: the Korean Society of Gynecologic Oncology guidelines Lee, BHY; Chang, SJ; Kwon, BS; Son, JH; Lim, MC; Kim, YH; Lee, SW; Choi, CH; Eoh, KJ; Lee, JY; Suh, DH; Kim, YB
    View PubMed
  • CANCER CELL INT 2024 10.1186/s12935-024-03235-2 The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression Lee, YY; Ryu, JY; Cho, YJ; Choi, JY; Choi, JJ; Choi, CH; Sa, JK; Hwang, JR; Lee, JW
    View PubMed
  • GLAND SURG 2024 10.21037/gs-23-249 Initial experience with the enhanced recovery after surgery (ERAS) protocols in gynecologic surgery at an urban academic tertiary medical center Kim, WJ; Noh, JJ; Bang, YJ; Yang, MY; Kim, JH; Park, CH; Song, HJ; Kim, JM; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Min, JJ; Kim, CS; Hahm, TS; Lee, YY
    View PubMed
  • BMC CANCER 2023 10.1186/s12885-023-11394-0 A differential diagnosis between uterine leiomyoma and leiomyosarcoma using transcriptome analysis Kim, K; Kim, S; Ahn, T; Kim, H; Shin, SJ; Choi, CH; Park, S; Kim, YB; No, JH; Suh, DH
    View PubMed
  • PLOS ONE 2023 10.1371/journal.pone.0294647 Impact of PARP inhibitor maintenance therapy in newly diagnosed advanced epithelial ovarian cancer: A meta-analysis Lee, B; Chang, SJ; Kwon, BS; Son, JH; Lim, MC; Kim, YH; Lee, SW; Choi, CH; Eoh, KJ; Lee, JY; Suh, DH; Kim, YB
    View PubMed
  • J IMMUNOTHER CANCER 2023 10.1136/jitc-2023-007444 Phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer: primary analysis in the original cohort of KGOG3046/TRU-D Park, J; Lee, JB; Lim, MC; Kim, BG; Kim, JW; Kim, S; Choi, CH; Kim, HS; Park, SY; Lee, JY; KGOG investigators
    View PubMed
  • NAT COMMUN 2023 10.1038/s41467-023-40829-2 Triplet maintenance therapy of olaparib, pembrolizumab and bevacizumab in women with BRCA wild-type, platinum-sensitive recurrent ovarian cancer: the multicenter, single-arm phase II study OPEB-01/APGOT-OV4 Kim, YN; Park, B; Kim, JW; Kim, BG; Kim, SW; Kim, HS; Choi, CH; Lim, MC; Ngoi, NYL; Tan, DSP; Lee, JY
    View PubMed
  • ANESTH ANALG 2023 10.1213/ANE.0000000000006358 The Effect of Intrathecal Morphine on Postoperative Opioid Consumption in Patients Undergoing Abdominal Surgery for Gynecologic Malignancy: A Randomized Sham-Controlled Trial Bang, YJ; Lee, EK; Kim, CS; Hahm, TS; Jeong, H; Cho, YJ; Noh, JJ; Lee, YY; Choi, CH; Lee, JW; Jeong, JS
    View PubMed
  • INT J CANCER 2023 10.1002/ijc.34696 Randomized, two-arm, noncomparative phase 2 study of olaparib plus cediranib or durvalumab in HRR-mutated, platinum-resistant ovarian cancer: A substudy of KGOG 3045 Kim, YN; Joung, JG; Park, E; Kim, JW; Lee, JB; Lim, J; Kim, S; Choi, CH; Kim, HS; Chung, JS; Kim, BG; Lee, JY
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13868-8 ASO Visual Abstract: Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity-Score-Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • ANN SURG ONCOL 2023 10.1245/s10434-023-13695-x Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan Chang, CS; Lai, YL; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Cheng, WF; Chen, YL; Lee, YY
    View PubMed
  • GYNECOL ONCOL 2023 10.1016/j.ygyno.2023.05.012 Survival outcomes of laparoscopic versus open radical hysterectomy in early cervical cancer with incidentally identified high-risk factors Kim, NR; Kim, SI; Suh, DH; Kim, HS; Kim, K; Chung, HH; No, JH; Kim, YB; Kim, JW; Park, NH; Song, YS; Choi, CH; Lee, M
    View PubMed
  • GYNECOL ONCOL 2023 10.1016/j.ygyno.2023.04.015 Conization before radical hysterectomy in patients with early-stage cervical cancer: A Korean multicenter study (COBRA-R) Kim, SI; Nam, SH; Hwangbo, S; Kim, Y; Cho, HW; Suh, DH; Song, JY; Kim, JW; Choi, CH; Kim, DY; Lee, MR
    View PubMed
  • J VASC INTERV RADIOL 2022 10.1016/j.jvir.2022.10.009 Arteriovenous Malformation Associated with Intravenous Leiomyomatosis of the Uterus: Characteristic CT Findings and Treatment by Embolization and Surgery Kim, JG; Park, YJ; Do, YS; Kim, BG; Lee, JW; Choi, CH; Kim, HC; Park, KB; Hyun, DH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.996516 Invisible cervical cancers on MRI: Can the type of histology (SCC versus non-SCC) influence surgical planning? Jeon, J; Park, BK; Lee, JW; Choi, CH; Lee, YY; Kim, TJ; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e71 Predicting prognosis according to the updated WHO classification in patients with endocervical adenocarcinoma treated with surgery and radiotherapy Cho, WK; Kim, HS; Park, W; Chang, CS; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003971 Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification Bae, BK; Cho, WK; Kim, BG; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Park, W
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.926878 Role of reactive thrombocytosis after primary cytoreductive surgery in advanced ovarian cancer Kim, MS; Baek, SH; Noh, JJ; Shim, JI; Kang, JH; Jeong, SY; Choi, CH; Kim, TJ; Lee, JW; Lee, YY
    View PubMed
  • CANCER BIOMARK 2022 10.3233/CBM-210077 Changes in subcellular localization of Lysyl-tRNA synthetase and the 67-kDa laminin receptor in epithelial ovarian cancer metastases Lee, DH; Paik, ES; Cho, YJ; Lee, YY; Lee, B; Lee, EJ; Choi, JJ; Choi, CH; Lee, S; Choi, JW; Lee, JW
    View PubMed
  • INT J GYNECOL CANCER 2022 10.1136/ijgc-2022-003834 Role of salvage radiotherapy for recurrent ovarian cancer Bae, BK; Cho, WK; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Park, W
    View PubMed
  • CANCERS 2022 10.3390/cancers14163863 The Role of Conization before Radical Hysterectomy in Cervical Cancer including High Risk Factors of Recurrence: Propensity Score Matching Chang, CS; Min, JS; Song, KH; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2022 10.3802/jgo.2022.33.e45 Biomarker-guided targeted therapy in platinum-resistant ovarian cancer (AMBITION; KGOG 3045): a multicentre, open-label, five-arm, uncontrolled, umbrella trial Lee, JY; Kim, BG; Kim, JW; Lee, JB; Park, E; Joung, JG; Kim, S; Choi, CH; Kim, HS
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2022.03.014 Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery Lim, H; Shim, JI; Park, SJ; Noh, J; Kim, TM; Lee, M; Choi, CH; Chung, HH; Kim, TJ; Lee, JW; Kim, JW; Kim, BG; Park, NH; Song, YS; Kim, SY; Park, SY; Kim, HS; Lee, YY
    View PubMed
  • CANCERS 2022 10.3390/cancers14092139 Prognostic Significance of HER3 Expression in Patients with Cervical Cancer Chang, CS; Shim, JI; Byeon, SJ; Lee, EJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • TAIWAN J OBSTET GYNE 2022 10.1016/j.tjog.2022.02.024 Clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience Kim, MS; Jeong, SY; Lee, YY; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • BMC CANCER 2022 10.1186/s12885-022-09429-z Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol Park, SJ; Kong, TW; Kim, T; Lee, M; Choi, CH; Shim, SH; Yim, GW; Lee, S; Lee, EJ; Lim, MC; Chang, SJ; Lee, SJ; Lee, SH; Song, T; Lee, YY; Kim, HS; Nam, EJ
    View PubMed
  • GYNECOL ONCOL 2022 10.1016/j.ygyno.2021.12.023 Cervical conization before primary radical hysterectomy has a protective effect on disease recurrence in early cervical cancer: A two-center matched cohort study according to surgical approach Kim, SI; Choi, BR; Kim, HS; Chung, HH; Kim, JW; Park, NH; Song, YS; Choi, CH; Lee, M
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2021.023 Effect of Waiting Time from Pathological Diagnosis to Definitive Concurrent Chemoradiation for Cervical Cancer on Overall Survival Noh, KW; Kim, B; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Cho, WK; Park, W; Lee, YY
    View PubMed
  • CANCERS 2022 10.3390/cancers14010224 Utility of 3T MRI in Women with IB1 Cervical Cancer in Determining the Necessity of Less Invasive Surgery Jeong, SY; Park, BK; Choi, CH; Lee, YY; Kim, TJ; Lee, JW; Kim, BG
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.770103 Prognostic Relevance of BRCA1 Expression in Survival of Patients With Cervical Cancer Paik, ES; Chang, CS; Chae, YL; Oh, SY; Byeon, SJ; Kim, CJ; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Choi, CH
    View PubMed
  • INT J GYNECOL CANCER 2021 10.1136/ijgc-2021-003017 Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001 Marth, C; Tarnawski, R; Tyulyandina, A; Pignata, S; Gilbert, L; Kaen, D; Rubio, MJ; Frentzas, S; Beiner, M; Magallanes-Maciel, M; Farrelly, L; Choi, CH; Berger, R; Lee, CE; Vulsteke, C; Hasegawa, K; Braicu, EI; Wu, XH; McKenzie, J; Lee, JJ; Makker, V
    View PubMed
  • J OBSTET GYNAECOL RE 2021 10.1111/jog.15078 Comparative performance of various human papillomavirus assays available in Korea for detecting cervical intraepithelial neoplasia Ouh, YT; Park, JJ; Kang, M; Kim, M; Song, JY; Shin, SJ; Shim, SH; Yoo, HJ; Lee, M; Lee, SJ; Shin, W; Chong, GO; Choi, MC; Choi, CH; Min, KJ
    View PubMed
  • CANCER SCI 2021 10.1111/cas.15166 Prevalence and clinical characterization of BRCA1 and BRCA2 mutations in Korean patients with epithelial ovarian cancer Paik, ES; Heo, EJ; Choi, CH; Kim, JH; Kim, JW; Kim, YM; Park, SY; Lee, JW; Kim, JW; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e72 Significance of serum CA125 level in surgically resected cervical adenocarcinoma with adverse features Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Choi, CH; Kim, TJ; Lee, YY
    View PubMed
  • CANCERS 2021 10.3390/cancers13153709 Machine Learning Models to Predict Survival Outcomes According to the Surgical Approach of Primary Radical Hysterectomy in Patients with Early Cervical Cancer Kim, SI; Lee, S; Choi, CH; Lee, M; Suh, DH; Kim, HS; Kim, K; Chung, HH; No, JH; Kim, JW; Park, NH; Song, YS; Kim, YB
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.1251 Early Metabolic Response Assessed Using F-18-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer Kim, N; Park, W; Cho, WK; Bae, DS; Kim, BG; Lee, JW; Kim, TJ; Choi, CH; Lee, YY; Cho, YS
    View PubMed
  • TAIWAN J OBSTET GYNE 2021 10.1016/j.tjog.2021.05.029 Single-port access (SPA) laparoscopic myomectomy with uterine artery ligation via a retroperitoneal approach is feasible in women with large uterine leiomyoma Noh, JJ; Kim, J; Paik, ES; Kang, JH; Jeong, SY; Choi, CH; Lee, YY; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e164 Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040) Ouh1, YT; Park, JJ; Kang, M; Kim, M; Song, JY; Shin, SJ; Shim, SH; Yoo, HJ; Lee, M; Lee, SJ; Shin, W; Chong, GO; Choi, MC; Choi, CH; Min, KJ
    View PubMed
  • GYNECOL ONCOL 2021 10.1016/j.ygyno.2021.02.009 Metabolic syndrome and persistent cervical human papillomavirus infection Lee1, J; Kim, HS; Kim, K; Bae, DS; Kim, BG; Choi, CH
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.670214 Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix Jung1, JH; Noh, JJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • J GYNECOL ONCOL 2021 10.3802/jgo.2021.32.e31 A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01) Lee1, YJ; Lim, MC; Kim, BG; Ngoi, NY; Choi, CH; Park, SY; Tan, DSP; Go, YJ; Lee, JY
    View PubMed
  • TAIWAN J OBSTET GYNECOL 2021 10.1016/j.tjog.2020.11.020 Vulvar epithelioid sarcoma: A case report with literature review Noh1, JJ; Jeon, JE; Jung, H; Kim, HS; Lee, YY; Choi, CH; Lee, JW
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9113471 Prognostic Significance of Tumor Regression Rate during Concurrent Chemoradiotherapy in Locally Advanced Cervix Cancer Analysis by Radiation Phase and Histologic Type Kang1, JH; Cho, WK; Yeo, HJ; Jeong, SY; Noh, JJ; Shim, JI; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Park, W; Choi, CH
    View PubMed
  • YONSEI MED J 2020 10.3349/ymj.2020.61.11.935 Survival Effects of Cytoreductive Surgery for Refractory Patients after Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer Shin1, W; Noh, JJ; Seo, SS; Kang, S; Choi, CH; Park, SY; Kim, BG; Lim, MC
    View PubMed
  • CURR PROB CANCER 2020 10.1016/j.currproblcancer.2020.100557 Triplet chemotherapy vs doublet chemotherapy plus bevacizumab in metastatic, recurrent, and persistent cervical cancer Choi1, HJ; Lee, YY; Choi, CH; Kim, TJ; Lee, JW; Bae, JH; Bae, DS; Kim, BG
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9092960 The Prognostic Model of Pre-Treatment Complete Blood Count (CBC) for Recurrence in Early Cervical Cancer Noh1, JJ; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH
    View PubMed
  • FRONT ONCOL 2020 10.3389/fonc.2020.583515 Feasibility of Single-Port Access (SPA) Laparoscopy for Large Ovarian Tumor Suspected to Be Borderline Ovarian Tumor Kang1, JH; Noh, JJ; Jeong, SY; Shim, JI; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, HS; Kim, TJ
    View PubMed
  • INT J GYNECOL CANCER 2020 10.1136/ijgc-2020-001604 A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA) Ngoi1, NYL; Heong, V; Ow, S; Chay, WY; Kim, HS; Choi, CH; Goss, G; Goh, JC; Tai, BC; Lim, DGZ; Kaliaperumal, N; Au, VB; Connolly, JE; Kim, JW; Friedlander, M; Kim, K; Tan, DSP
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2020.02.017 Chemoradiotherapy response prediction model by proteomic expressional profiling in patients with locally advanced cervical cancer Choi1, CH; Chung, JY; Kang, JH; Paik, ES; Lee, YY; Park, W; Byeon, SJ; Chung, EJ; Kim, BG; Hewitt, SM; Bae, DS
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.509 Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients Cho1, MA; Jeong, SY; Sohn, I; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Choi, CH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9041137 Identification of Candidate Genes Associated with Susceptibility to Ovarian Clear Cell Adenocarcinoma Using cis-eQTL Analysis Kim1, J; Chung, JY; Hwang, JR; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • Front Oncol 2020 10.3389/fonc.2020.00451 Comparison of Laparoscopy and Laparotomy for Para-Aortic Lymphadenectomy in Women With Presumed Stage I-II High-Risk Endometrial Cancer Paik1, ES; Baek, SH; Kang, JH; Jeong, SY; Kim, MS; Kim, WY; Lee, YY; Choi, CH; Lee, JW; Kim, BG; Bae, DS; Kim, TJ
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.328 Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status Jeong1, SY; Park, H; Kim, MS; Kang, JH; Paik, ES; Lee, YY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J OBSTET GYNAECOL RE 2020 10.1111/jog.14171 Effectiveness of adjuvant treatment for morcellated, International Federation of Gynecology and Obstetrics stage I uterine leiomyosarcoma: A Korean multicenter study Kim1, SI; Choi, CH; Kim, K; Hong, DH; Park, JY; Kwon, BS; Lee, KH; Hong, DG; Shin, SJ; Park, SI; Kim, YH; Lee, SH; Lee, S; Hong, JH; Lee, JY; Kim, YB; No, JH; Suh, DH
    View PubMed
  • GYNECOL ONCOL 2020 10.1016/j.ygyno.2019.11.004 CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer Kim1, J; Cho, YJ; Ryu, JY; Hwang, I; Han, HD; Ahn, HJ; Kim, WY; Cho, H; Chung, JY; Hewitt, SM; Kim, JH; Kim, BG; Bae, DS; Choi, CH; Lee, JW
    View PubMed
  • CANCER RES TREAT 2020 10.4143/crt.2019.124 Prognostic Model for Survival and Recurrence in Patients with Early-Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028) Paik1, ES; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH
    View PubMed
  • J CLIN MED 2020 10.3390/jcm9010147 Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16-or 18-Positive Recurrent Cervical Cancer Choi1, CH; Choi, HJ; Lee, JW; Kang, ES; Cho, D; Park, BK; Kim, YM; Kim, DY; Seo, H; Park, M; Kim, W; Choi, KY; Oh, T; Kang, CY; Kim, BG
    View PubMed
  • Cancer Res Treat. 2019 Aug 5. doi: 10.4143/crt.2019.124. [Epub ahead of print] Prognostic Model for Survival and Recurrence in Patients with Early Stage Cervical Cancer: A Korean Gynecologic Oncology Group Study (KGOG 1028) Paik ES1, Lim MC, Kim MH, Kim YH, Song ES, Seong SJ, Suh DH, Lee JM, Lee C, Choi CH.
    View PubMed
  • J OVARIAN RES 2019 10.1186/s13048-019-0602-5 Interval between secondary cytoreductive surgery and adjuvant chemotherapy is not associated with survivals in patients with recurrent ovarian cancer Jeong1, SY; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Lee, YY
    View PubMed
  • EUR RADIOL 2019 10.1007/s00330-019-06204-w Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy Gu1, KW; Kim, CK; Choi, CH; Yoon, YC; Park, W
    View PubMed
  • J CLIN MED 2019 10.3390/jcm8111920 Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study Paik1, ES; Lee, YJ; Lee, JY; Shin, W; Park, SY; Kim, SI; Kim, JW; Choi, CH; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e112 A phase II study of neoadjuvant chemotherapy plus durvalumab and tremelimumab in advanced-stage ovarian cancer: a Korean Gynecologic Oncology Group Study (KGOG 3046), TRU-D Lee1, JY; Kim, JW; Lim, MC; Kim, S; Kim, HS; Choi, CH; Yi, JY; Park, SY; Kim, BG; Nam, EJ; Kim, SW; Eoh, KJ; Lee, YJ; Roh, J; Kim, HM; Rae, DS; Lee, JW; Kim, TJ; Lee, YY; Choi, EH; Song, S; Kim, HS; Lee, M; Kim, SI; Lee, EJ; Kwon, SI; Shin, W; Seo, SS; Kang, S; Kim, MS; Kim, JS; Joung, J; Chung, J
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-51959-3 Anti-Tumor Effects of Wee1 Kinase Inhibitor with Radiotherapy in Human Cervical Cancer Lee1, YY; Cho, YJ; Shin, SW; Choi, C; Ryu, JY; Jeon, HK; Choi, JJ; Hwang, JR; Choi, CH; Kim, TJ; Kim, BG; Bae, DS; Park, W; Lee, JW
    View PubMed
  • GYNECOL ONCOL 2019 10.1016/j.ygyno.2019.06.023 Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028) Paik1, ES; Lim, MC; Kim, MH; Kim, YH; Song, ES; Seong, SJ; Suh, DH; Lee, JM; Lee, C; Choi, CH
    View PubMed
  • JPN J CLIN ONCOL 2019 10.1093/jjco/hyz085 An umbrella study of biomarker-driven targeted therapy in patients with platinum-resistant recurrent ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG 3045), AMBITION Lee1, JY; Yi, JY; Kim, HS; Lim, J; Kim, S; Nam, BH; Kim, HS; Kim, JW; Choi, CH; Kim, BG
    View PubMed
  • EUR J GYNAECOL ONCOL 2019 10.12892/ejgo4827.2019 Mesonephric adenocarcinoma treated with paclitaxel-carboplatin adjuvant chemotherapy: a case report Noh1, JJ; Jung, H; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e65 Prediction of survival outcomes in patients with epithelial ovarian cancer using machine learning methods Paik1, ES; Lee, JW; Park, JY; Kim, JH; Kim, M; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Seo, SW
    View PubMed
  • J GYNECOL ONCOL 2019 10.3802/jgo.2019.30.e11 Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff? Kim1, J; Chang, Y; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2017.361 Development and Validation of Ovarian Symptom Index-18 and Neurotoxcity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Lee1, M; Lee, Y; Kim, K; Park, EY; Lim, MC; Kim, JS; Kim, HS; Kim, YB; Kim, YM; Joo, J; Park, SY; Choi, CH; Kim, JH
    View PubMed
  • Front Oncol. 2018 Oct 23;8:465. doi: 10.3389/fonc.2018.00465. eCollection 2018. Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma Jihye Kim1, Joon-Yong Chung, Tae-Joong Kim, Jeong-Won Lee, Byoung-Gie Kim, Duk-Soo Bae, Chel Hun Choi, Stephen M Hewitt
    View PubMed
  • Tumour Biol. 2018 Oct;40(10):1010428318808678. doi: 10.1177/1010428318808678. Dual loss of USP10 and p14ARF protein expression is associated with poor prognosis in patients with small intestinal adenocarcinoma Joon Seon Song1, Joo Mi Yi, Hanbyoul Cho, Chel Hun Choi, Yoonho Park, Eun Joo Chung, Jaewhan Song, Joon-Yong Chung, Seung-Mo Hong
    View PubMed
  • Front Oncol 2018 10.3389/fonc.2018.00465 Genomic Network-Based Analysis Reveals Pancreatic Adenocarcinoma Up-Regulating Factor-Related Prognostic Markers in Cervical Carcinoma Kim1, J; Chung, JY; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH; Hewitt, SM
    View PubMed
  • EUR J OBSTET GYN R B 2018 10.1016/j.ejogrb.2018.06.034 The role of appendectomy in patients with mucinous borderline ovarian tumors Song1, T; Kim, MK; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001316 Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix A Retrospective Analysis Choi1, HJ; Paik, ES; Choi, CH; Kim, TJ; Lee, YY; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • SCI REP-UK 2018 10.1038/s41598-018-30582-8 Elevated expression of pancreatic adenocarcinoma upregulated factor (PAUF) is associated with poor prognosis and chemoresistance in epithelial ovarian cancer Choi1, CH; Kang, TH; Song, JS; Kim, YS; Chung, EJ; Ylaya, K; Kim, S; Koh, SS; Chung, JY; Kim, JH; Hewitt, SM
    View PubMed
  • ONCOGENE 2018 10.1038/s41388-018-0267-3 Ubiquitylation and degradation of adenomatous polyposis coli by MKRN1 enhances Wnt/beta-catenin signaling Lee1, HK; Lee, EW; Seo, J; Jeong, M; Lee, SH; Kim, SY; Jho, EH; Choi, CH; Chung, JY; Song, J
    View PubMed
  • INT J GYNECOL CANCER 2018 10.1097/IGC.0000000000001270 Three-Year Recurrence-Free Survival in Patients With a Very Low Risk of Endometrial Cancer Who Did Not Undergo Lymph Node Dissection (Tree Retro): A Korean Multicenter Study Kim1, M; Choi, C; Kim, K; Lim, MC; Park, JY; Hong, JH; Lee, M; Paek, J; Seoung, J; Lee, S; Lee, TS
    View PubMed
  • CELL DEATH DIFFER 2018 10.1038/s41418-018-0072-0 Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF Ko1, A; Han, SY; Choi, CH; Cho, H; Lee, MS; Kim, SY; Song, JS; Hong, KM; Lee, HW; Hewitt, SM; Chung, JY; Song, J
    View PubMed
  • CANCER RES 2018 10.1158/0008-5472.CAN-17-2325 Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis Oh1, SJ; Cho, H; Kim, S; Noh, KH; Song, KH; Lee, HJ; Woo, SR; Kim, S; Choi, CH; Chung, JY; Hewitt, SM; Kim, JH; Baek, S; Lee, KM; Yee, C; Park, HC; Kim, TW
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.104 Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer Paik1, ES; Choi, HJ; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e18 Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis Paik1, ES; Kim, TJ; Choi, CH; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • GYNECOL OBSTET INVES 2018 10.1159/000475817 Elevated Preoperative CA125 or CA19-9 in Borderline Ovarian Tumors: Could It Be Suggestive of Advanced Stage or a Poor Prognosis? Song1, T; Lee, DH; Jung, YW; Yun, BS; Seong, SJ; Choi, CH; Lee, JW; Bae, DS; Kim, BG
    View PubMed
  • J GYNECOL ONCOL 2018 10.3802/jgo.2018.29.e13 Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer Paik1, ES; Kim, JH; Kim, TJ; Lee, JW; Kim, BG; Bae, DS; Choi, CH
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.322 Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies Heo1, EJ; Cho, YJ; Cho, WC; Hong, JE; Jeon, HK; Oh, DY; Choi, YL; Song, SY; Choi, JJ; Bae, DS; Lee, YY; Choi, CH; Kim, TJ; Park, WY; Kim, BG; Lee, JW
    View PubMed
  • CANCER RES 2017 10.1158/0008-5472.CAN-17-0072 HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells Song1, KH; Choi, CH; Lee, HJ; Oh, SJ; Woo, SR; Hong, SO; Noh, KH; Cho, H; Chung, EJ; Kim, JH; Chung, JY; Hewitt, SM; Baek, S; Lee, KM; Yee, C; Son, M; Mao, CP; Wu, TC; Kim, TW
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.034 Proton. Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer Song1, T; Jeon, HK; Hong, JE; Choi, JJ; Kim, TJ; Choi, CH; Bae, DS; Kim, BG; Lee, JW
    View PubMed
  • SCI REP-UK 2017 10.1038/s41598-017-06510-7 The anti-cancer effects of itraconazole in epithelial ovarian cancer Choi1, CH; Ryu, JY; Cho, YJ; Jeon, HK; Choi, JJ; Ylaya, K; Lee, YY; Kim, TJ; Chung, JY; Hewitt, SM; Kim, BG; Bae, DS; Lee, JW
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.282 Nomograms Predicting Platinum Sensitivity, Progression-Free Survival, and Overall Survival Using Pretreatment Complete Blood Cell Counts in Epithelial Ovarian Cancer Paik1, ES; Sohn, I; Baek, SY; Shim, M; Choi, HJ; Kim, TJ; Choi, CH; Lee, JW; Kim, BG; Lee, YY; Bae, DS
    View PubMed
  • Eur J Cancer Prev. 2017 Jan;26(1):78-85. The effect of angiotensin system inhibitors (angiotensin-converting enzyme inhibitors or angiotensin receptor blockers) on cancer recurrence and survival: a meta-analysis Song T11, Choi CH, Kim MK, Kim ML, Yun BS, Seong SJ.
    View PubMed
  • Cancer Res. 2017 Jan 15;77(2):343-354. doi: 10.1158/0008-5472.CAN-16-0613. Epub 2016 Oct 28. Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF Han SY11, Ko A1, Kitano H2,3, Choi CH2,4, Lee MS1, Seo J1, Fukuoka J5, Kim SY6, Hewitt SM2, Chung JY2, Song J7.
    View PubMed
  • Oncogenesis. 2017 Jan 16;6(1):e285. doi: 10.1038/oncsis.2016.87. API5 confers cancer stem cell-like properties through the FGF2-NANOG axis Song KH11,2,3, Cho H4,5,6, Kim S7, Lee HJ1,2,3, Oh SJ1,2,3, Woo SR1,2, Hong SO1,2, Jang HS1,2,3, Noh KH1,2, Choi CH4,8, Chung JY4, Hewitt SM4, Kim JH5,6, Son M9, Kim SH10, Lee BI11, Park HC7, Bae YK12, Kim TW1,2,3.
    View PubMed
  • J Gynecol Oncol. 2017 Jan;28(1):e5. doi: 10.3802/jgo.2017.28.e5. Epub 2016 Aug 19. Surgical manual of the Korean Gynecologic Oncology Group: classification of hysterectomy and lymphadenectomy Lee M11, Choi CH2, Chun YK3, Kim YH4, Lee KB5, Lee SW6, Shim SH7, Song YJ8, Roh JW9, Chang SJ10, Lee JM11.
    View PubMed
  • Sci Rep. 2016 Dec 5;6:38502. doi: 10.1038/srep38502. c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma Kim HJ11, Yoon A2, Ryu JY2, Cho YJ2, Choi JJ2, Song SY3, Bang H3, Lee JS4, Cho WC5, Choi CH2, Lee JW2,6,7, Kim BG2, Bae DS2.
    View PubMed
  • Anticancer Res. 2016 Dec;36(12):6381-6388. Dynamin 2 Inhibitors as Novel Therapeutic Agents Against Cervical Cancer Cells Lee YY11, Jeon HK2, Lee J3, Hong JE2, Do IG4, Choi CH2, Kim TJ2, Kim BG2, Bae DS2, Kim YC3, Lee JW5.
    View PubMed
  • Cancer Biomark. 2016;17(4):419-425. doi: 10.3233/CBM-160658. Preoperative multiplication of neutrophil and monocyte counts as a prognostic factor in epithelial ovarian cancer Paik ES1, Shim M, Choi HJ, Lee YY, Kim TJ, Choi CH, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):639-647. doi: 10.1111/ajo.12529. Epub 2016 Sep 9. Timing and patterns of recurrence in epithelial ovarian cancer patients with no gross residual disease after primary debulking surgery Paik ES11, Lee YY1, Shim M1, Choi HJ1, Kim TJ1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Gynecol Oncol. 2016 Nov;143(2):252-257. doi: 10.1016/j.ygyno.2016.08.321. Epub 2016 Aug 25. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis Paik ES11, Shim M1, Choi HJ1, Lee YY2, Kim TJ1, Lee JW1, Kim BG1, Bae DS1, Choi CH3.
    View PubMed
  • Oncotarget. 2016 Nov 22;7(47):77052-77070. doi: 10.18632/oncotarget.12784. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer Kwon M11, Kim JH2,3, Rybak Y1, Luna A1, Choi CH4,5, Chung JY5, Hewitt SM5, Adem A1, Tubridy E1, Lin J6, Libutti SK1.
    View PubMed
  • Lab Invest. 2016 Oct;96(10):1116-27. doi: 10.1038/labinvest.2016.90. Epub 2016 Aug 22. A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue Chung JY11, Choi J2, Sears JD1, Ylaya K1, Perry C1,3, Choi CH1,4, Hong SM5, Cho H1,6, Brown KM2, Hewitt SM1.
    View PubMed
  • J Gynecol Oncol. 2016 Sep;27(5):e46. doi: 10.3802/jgo.2016.27.e46. Epub 2016 May 9. Comparison of survival outcomes after recurrence detected by cancer antigen 125 elevation versus imaging study in epithelial ovarian cancer Paik ES11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Kim BG1, Bae DS1.
    View PubMed
  • Int J Gynecol Cancer. 2016 Sep;26(7):1252-7. doi: 10.1097/IGC.0000000000000762. Long-term Outcomes of MRI Stage IIB Cervical Cancer Yoon A11, Park JJ, Park BK, Lee YY, Paik ES, Choi CH, Kim TJ, Kim CK, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2016 Jul;27(4):e38. doi: 10.3802/jgo.2016.27.e38. Epub 2016 Apr 18. Long-term outcomes of magnetic resonance imaging-invisible endometrial cancer Choi HJ11, Lee S2, Park BK3, Kim TJ1, Kim CK2, Park JJ2, Choi CH1, Lee YY1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • J Histochem Cytochem. 2016 Jul;64(7):425-40. doi: 10.1369/0022155416649579. Epub 2016 May 24. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications Perry C11, Chung JY1, Ylaya K1, Choi CH1, Simpson A1, Matsumoto KT1, Smith WA1, Hewitt SM2.
    View PubMed
  • BMC Cancer. 2016 Jul 11;16:448. doi: 10.1186/s12885-016-2459-y. Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer Choi CH11,2, Chung JY1, Chung EJ3, Sears JD1, Lee JW2, Bae DS4, Hewitt SM5.
    View PubMed
  • J Gynecol Oncol. 2016 May;27(3):e24. doi: 10.3802/jgo.2016.27.e24. Feasibility of laparoscopic cytoreduction in patients with localized recurrent epithelial ovarian cancer Paik ES11, Lee YY1, Kim TJ1, Choi CH1, Lee JW2, Kim BG1, Bae DS1.
    View PubMed
  • J Transl Med. 2016 May 6;14(1):124. doi: 10.1186/s12967-016-0874-0. Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patients Choi CH11,2, Chung JY1, Kim JH3, Kim BG4, Hewitt SM5.
    View PubMed
  • JSLS. 2016 Apr-Jun;20(2). pii: e2016.00001. doi: 10.4293/JSLS.2016.00001 Retroperitoneal Approach in Single-Port Laparoscopic Hysterectomy Kim TH11, Kim CJ1, Kim TJ2, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • Radiology. 2016 Mar;278(3):925-35. doi: 10.1148/radiol.2015150608. Epub 2015 Aug 27. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Lee JW1, Choi CH1, Kim BG1, Bae DS1, Rhim H1, Lim HK1.
    View PubMed
  • Arch Gynecol Obstet. 2016 Jan;293(1):157-62. doi: 10.1007/s00404-015-3801-3. Epub 2015 Jul 9. Clinical outcomes of primary surgical treatment for acquired vulvar lymphangioma circumscriptum Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Kim BG3, Bae DS3, Hwang JH4, Lee JW5.
    View PubMed
  • BMC Cancer. 2015 Dec 26;15:1015. doi: 10.1186/s12885-015-2015-1. Clinical significance of OCT4 and SOX2 protein expression in cervical cancer Kim BW11,2, Cho H3, Choi CH4,5, Ylaya K6, Chung JY7, Kim JH8, Hewitt SM9.
    View PubMed
  • Oncotarget. 2015 Oct 27;6(33):35040-50. doi: 10.18632/oncotarget.5319. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma Lee YY11, Jeon HK1, Hong JE1, Cho YJ1, Ryu JY1, Choi JJ1, Lee SH2, Yoon G3, Kim WY4, Do IG5, Kim MK6, Kim TJ1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Pathobiology. 2015;82(5):203-11. doi: 10.1159/000434726. Epub 2015 Aug 25. Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer Choi CH11, Chung JY, Cho H, Kitano H, Chang E, Ylaya K, Chung EJ, Kim JH, Hewitt SM.
    View PubMed
  • Oncotarget. 2015 Sep 29;6(29):26746-56. doi: 10.18632/oncotarget.4818. Sphingosine kinase 1 is a reliable prognostic factor and a novel therapeutic target for uterine cervical cancer Kim HS11, Yoon G2, Ryu JY3, Cho YJ3, Choi JJ3, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3,5.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:48-51. doi: 10.1016/j.ejogrb.2015.04.014. Epub 2015 May 1. A prospective comparative study of cosmetic satisfaction for three different surgical approaches Song T11, Park JY2, Kim TJ3, Lee YY2, Choi CH2, Lee JW2, Bae DS2, Kim BG2.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jul;190:26-30. doi: 10.1016/j.ejogrb.2015.04.005. Epub 2015 Apr 16. The effect of coexisting squamous cell lesions on prognosis in patients with cervical adenocarcinoma in situ Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Cancer. 2015 Jul 1;137(1):221-9. doi: 10.1002/ijc.29362. Epub 2014 Dec 8. Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer Lee JW11, Ryu JY, Yoon G, Jeon HK, Cho YJ, Choi JJ, Song SY, Do IG, Lee YY, Kim TJ, Choi CH, Kim BG, Bae DS.
    View PubMed
  • J Gynecol Oncol. 2015 Jul;26(3):222-6. doi: 10.3802/jgo.2015.26.3.222. Robotic high para-aortic nymph node dissection with high port placement using same port for pelvic surgery in gynecologic cancer patients Kim TJ11, Yoon G2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG3.
    View PubMed
  • Int J Gynecol Cancer. 2015 Jul;25(6):1051-7. doi: 10.1097/IGC.0000000000000407. Perioperative Outcomes of Radical Trachelectomy in Early-Stage Cervical Cancer Vaginal Versus Laparoscopic Approaches Yoon A11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Hum Pathol. 2015 Jun;46(6):884-93. doi: 10.1016/j.humpath.2015.02.016. Epub 2015 Mar 11. Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients Choi CH11, Chung JY2, Park HS3, Jun M2, Lee YY4, Kim BG5, Hewitt SM6.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5318-26. eCollection 2015. Mesothelial cell inclusions in pelvic and para-aortic lymph nodes: a clinicopathologic analysis Kim HS11, Yoon G2, Lee YY3, Kim TJ3, Choi CH3, Lee JW3, Kim BG3, Bae DS3, Song SY4.
    View PubMed
  • Diagn Pathol. 2015 May 29;10:53. doi: 10.1186/s13000-015-0290-4. Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array Braunschweig T11,2, Chung JY3, Choi CH4,5, Cho H6,7, Chen QR8,9, Xie R10, Perry C11,12, Khan J13, Hewitt SM14.
    View PubMed
  • Int J Gynecol Cancer. 2015 May;25(4):688-93. doi: 10.1097/IGC.0000000000000404. Correlation Between Location of Transposed Ovary and Function in Cervical Cancer Patients Who Underwent Radical Hysterectomy Yoon A11, Lee YY, Park W, Huh SJ, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Clin Exp Pathol. 2015 May 1;8(5):5688-94. eCollection 2015. Analysis of clinical outcomes of patients with adenoid cystic carcinoma of Bartholin glands Yoon G11, Kim HS2, Lee YY3, Kim TJ3, Choi CH3, Song SY4, Kim BG3, Bae DS3, Lee JW3.
    View PubMed
  • Taiwan J Obstet Gynecol. 2015 Apr;54(2):150-4. doi: 10.1016/j.tjog.2014.05.005. Is laparoendoscopic single-site surgery (LESS) retroperitoneal hysterectomy feasible: Surgical outcomes of the initial 27 cases Kim TH11, Kim TJ2, Yoo HN1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2015 Jan;184:38-42. doi: 10.1016/j.ejogrb.2014.10.001. Epub 2014 Oct 14. Borderline ovarian tumor in women aged >= 65 years: impact on recurrence and survival Song T11, Lee YY2, Choi CH2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • J Gynecol Oncol. 2015 Jan;26(1):62-7. doi: 10.3802/jgo.2015.26.1.62. Single-site robotic surgery in gynecologic cancer: a pilot study Yoo HN11, Kim TJ2, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG1.
    View PubMed
  • Radiology. 2014 Nov;273(2):462-71. doi: 10.1148/radiol.14132719. Epub 2014 Jul 1. Uterine Fibroids: Semiquantitative Perfusion MR Imaging Parameters Associated with the Intraprocedural and Immediate Postprocedural Treatment Efficiencies of MR Imaging-guided High-Intensity Focused Ultrasound Ablation Kim YS11, Kim BG, Rhim H, Bae DS, Lee JW, Kim TJ, Choi CH, Lee YY, Lim HK.
    View PubMed
  • Int J Gynecol Cancer. 2014 Nov;24(9 Suppl 3):S30-4. doi: 10.1097/IGC.0000000000000293. Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Small Cell Cancers Reed NS11, Pautier P, Avall-Lundqvist E, Choi CH, du Bois A, Friedlander M, Fyles A, Kichenadasse G, Provencher DM, Ray-Coquard I.
    View PubMed
  • Int J Gynecol Cancer. 2014 Oct;24(8):1466-73. doi: 10.1097/IGC.0000000000000232. Robotic Versus Laparoscopic Radical Hysterectomy in Cervical Cancer Patients A Matched-Case Comparative Study Kim TH11, Choi CH, Choi JK, Yoon A, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2014 Oct;135(1):108-17. doi: 10.1016/j.ygyno.2014.06.031. Epub 2014 Jul 9. Dual targeting of angiotensin receptors (AGTR1 and AGTR2) in epithelial ovarian carcinoma Park YA11, Choi CH1, Do IG2, Song SY2, Lee JK3, Cho YJ1, Choi JJ1, Jeon HK1, Ryu JY1, Lee YY1, Kim TJ1, Bae DS1, Lee JW4, Kim BG5.
    View PubMed
  • Taiwan J Obstet Gynecol. 2014 Sep;53(3):343-7. doi: 10.1016/j.tjog.2013.10.041. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings Kim HJ11, Choi CH2, Lee YY2, Kim TJ2, Lee JW2, Bae DS2, Kim BG3.
    View PubMed
  • Int J Gynecol Cancer. 2014 Sep;24(7):1299-305. doi: 10.1097/IGC.0000000000000197. Prognostic Factors Influencing Decisions About Surgical Treatment of Villoglandular Adenocarcinoma of the Uterine Cervix Kim HJ11, Sung JH, Lee E, Ahn S, Song SY, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.
    View PubMed
  • Am J Obstet Gynecol. 2014 Aug;211(2):168.e1-7. doi: 10.1016/j.ajog.2014.02.032. Epub 2014 Mar 4. Postoperative outcomes of MR-invisible stage IB1 cervical cancer Park JY11, Lee JW1, Park BK2, Lee YY1, Choi CH1, Kim TJ1, Bae DS1, Kim BG1, Park JJ3, Park SY3, Kim CK3.
    View PubMed
  • J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):580-5. doi: 10.1016/j.jmig.2013.12.096. Epub 2013 Dec 31. Surgical Outcomes of a New Approach to Laparoscopic Myomectomy: Single-Port and Modified Suture Technique Choi CH11, Kim TH1, Kim SH1, Choi JK1, Park JY1, Yoon A1, Lee YY1, Kim TJ1, Lee JW1, Kim BG1, Bae DS2.
    View PubMed
  • J Cancer Res Clin Oncol. 2014 Jul;140(7):1179-88. doi: 10.1007/s00432-014-1658-7. Epub 2014 Mar 27. Meta-analysis of the effects of beta blocker on survival time in cancer patients Choi CH11, Song T, Kim TH, Choi JK, Park JY, Yoon A, Lee YY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Support Care Cancer. 2014 May;22(5):1181-7. doi: 10.1007/s00520-013-2070-6. Epub 2013 Dec 12. Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin Choi CH11, Kim MK, Park JY, Yoon A, Kim HJ, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Laparoendosc Adv Surg Tech A. 2014 Apr;24(4):254-9. doi: 10.1089/lap.2013.0507. Epub 2014 Feb 25. Comparison of Laparoendoscopic Single-Site Hysterectomies: Laparoscopic Hysterectomy with Some Vaginal Component Versus Laparoscopically Assisted Vaginal Hysterectomy Kim TJ11, Song T, Choi CH, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:58-61. doi: 10.1016/j.ejogrb.2014.01.004. Epub 2014 Jan 17. Laparoendoscopic single-site (LESS) myomectomy: characteristics of the appropriate myoma Yoon A11, Kim TJ1, Lee YY1, Choi CH1, Lee JW1, Bae DS1, Kim BG2.
    View PubMed
  • Clin Cancer Res. 2014 Feb 1;20(3):565-75. doi: 10.1158/1078-0432.CCR-13-1271. Epub 2013 Nov 6. Tumor Suppressive Effects of Bromodomain-Containing Protein 7 (BRD7) in Epithelial Ovarian Carcinoma Park YA11, Lee JW, Kim HS, Lee YY, Kim TJ, Choi CH, Choi JJ, Jeon HK, Cho YJ, Ryu JY, Kim BG, Bae DS.
    View PubMed
  • Gynecol Oncol. 2014 Jan;132(1):70-5. doi: 10.1016/j.ygyno.2013.10.029. Epub 2013 Oct 31. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases Yoon A11, Park JY2, Park JY1, Lee YY1, Kim TJ1, Choi CH1, Bae DS1, Kim BG1, Lee JW3, Nam JH4.
    View PubMed
  • Int J Gynecol Cancer. 2014 Jan;24(1):107-12. doi: 10.1097/IGC.0000000000000015. Bone Metastasis in Primary Endometrial Carcinoma Features, Outcomes, and Predictors Yoon A11, Choi CH, Kim TH, Choi JK, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Obstet Invest. 2013;76(4):241-7. doi: 10.1159/000356072. Epub 2013 Nov 1. Endocervical-Like versus intestinal-Type Mucinous Borderline Ovarian Tumors: A Large Retrospective Series Focusing on the Clinicopatholigic Characteristics Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Sung CO, Song SY, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2013 Sep;23(7):1311-7. doi: 10.1097/IGC.0b013e31829da127. Contributing Factors for Bone Metastasis in Uterine Cervical Cancer Yoon A11, Choi CH, Kim HJ, Park JY, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Hum Pathol. 2013 Jun;44(6):1017-23. doi: 10.1016/j.humpath.2012.08.024. Epub 2013 Jan 3. Overexpression of annexin A4 is associated with chemoresistance in papillary serous adenocarcinoma of the ovary Choi CH11, Sung CO, Kim HJ, Lee YY, Song SY, Song T, Kim J, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer Genet. 2013 May;206(5):145-53. doi: 10.1016/j.cancergen.2013.04.002. Epub 2013 May 29. Integrative analysis of copy number alteration and gene expression profiling in ovarian clear cell adenocarcinoma Sung CO11, Choi CH, Ko YH, Ju H, Choi YL, Kim N, Kang SY, Ha SY, Choi K, Bae DS, Lee JW, Kim TJ, Song SY, Kim BG.
    View PubMed
  • Ann Surg Oncol. 2012 Nov;19(12):3839-48. doi: 10.1245/s10434-012-2406-3. Epub 2012 May 30. Comparison of Laparoscopic-Assisted Radical Vaginal Hysterectomy and Laparoscopic Radical Hysterectomy in the Treatment of Cervical Cancer Choi CH11, Lee JW, Lee YY, Kim HJ, Song T, Kim MK, Kim TJ, Kim BG, Bae DS.
    View PubMed
  • Gynecol Oncol. 2012 Jul;126(1):124-31. doi: 10.1016/j.ygyno.2012.04.020. Epub 2012 Apr 21. Angiotensin II type I receptor and miR-155 in endometrial cancers: Synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells Choi CH11, Park YA, Choi JJ, Song T, Song SY, Lee YY, Lee JW, Kim TJ, Kim BG, Bae DS.
    View PubMed
  • Br J Cancer. 2012 Jun 26;107(1):91-9. doi: 10.1038/bjc.2012.217. Epub 2012 May 29. Identification of differentially expressed genes according to chemosensitivity in advanced ovarian serous adenocarcinomas: expression of GRIA2 predicts better survival Choi CH11, Choi JJ, Park YA, Lee YY, Song SY, Sung CO, Song T, Kim MK, Kim TJ, Lee JW, Kim HJ, Bae DS, Kim BG.
    View PubMed
  • J Sex Med. 2012 Jun;9(6):1697-704. doi: 10.1111/j.1743-6109.2012.02723.x. Epub 2012 Apr 30. Sexual Function after Surgery for Early-Stage Cervical Cancer: Is There a Difference in It According to the Extent of Surgical Radicality Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Ann Surg Oncol. 2012 Jun;19(6):1973-9. doi: 10.1245/s10434-011-2148-7. Epub 2011 Dec 20. Safe Criteria for Less Radical Trachelectomy in Patients with Early-Stage Cervical Cancer: A Multicenter Clinicopathologic Study Kim HS11, Choi CH, Lim MC, Chang SJ, Kim YB, Kim MA, Kim TJ, Park SY, Kim BG, Song YS, Bae DS, Kim JW.
    View PubMed
  • Gynecol Oncol. 2012 May;125(2):427-32. doi: 10.1016/j.ygyno.2012.01.030. Epub 2012 Jan 28. Expression of 67-kDa laminin receptor was associated with tumor progression and poor prognosis in epithelial ovarian cancer Song T11, Choi CH, Cho YJ, Sung CO, Song SY, Kim TJ, Bae DS, Lee JW, Kim BG.
    View PubMed
  • Gynecol Oncol. 2012 Jan;124(1):92-7. doi: 10.1016/j.ygyno.2011.09.034. Epub 2011 Oct 19. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: Comparison with SCC-Ag level Lee YY11, Choi CH, Sung CO, Do IG, Huh S, Song T, Kim MK, Kim HJ, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1252-7. doi: 10.1016/j.ijrobp.2010.07.2006. Epub 2010 Nov 13. A MATCHED-CASE COMPARISON TO EXPLORE THE ROLE OF CONSOLIDATION CHEMOTHERAPY AFTER CONCURRENT CHEMORADIATION IN CERVICAL CANCER Choi CH11, Lee YY, Kim MK, Kim TJ, Lee JW, Nam HR, Huh SJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2011 Sep;22(3):203-6. doi: 10.3802/jgo.2011.22.3.203. Epub 2011 Sep 28. Chemo-resistant choriocarcinoma metastatic to colon cured by low-anterior resection Ryu JH11, Choi CH, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Hum Reprod. 2011 Aug;26(8):2008-14. doi: 10.1093/humrep/der119. Epub 2011 Apr 21. Oncologic and reproductive outcomes of cystectomy compared with oophorectomy as a treatment for borderline ovarian tumours Song T11, Hun Choi C, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Jul;122(1):127-31. doi: 10.1016/j.ygyno.2011.03.021. Epub 2011 Apr 13. Accuracy of frozen section diagnosis of borderline ovarian tumors Song T11, Choi CH, Kim HJ, Kim MK, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2011 Jun;156(2):204-8. doi: 10.1016/j.ejogrb.2011.01.009. Epub 2011 Feb 8. Oncologic and reproductive outcomes in patients with advanced-stage borderline ovarian tumors Song T11, Choi CH, Kim HJ, Lee W, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • J Gynecol Oncol. 2011 Jun 30;22(2):83-8. doi: 10.3802/jgo.2011.22.2.83. Which is worse: uterine papillary serous carcinomas or carcinosarcomas Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2011 May;21(4):640-6. doi: 10.1097/IGC.0b013e3182129842. Fertility-Sparing Surgery for Borderline Ovarian Tumors Oncologic Safety and Reproductive Outcomes Song T11, Choi CH, Park HS, Kim MK, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Cancer. 2011 May 15;117(10):2104-11. doi: 10.1002/cncr.25710. Epub 2010 Nov 29. Phase II Study of Belotecan, a Camptothecin Analogue, in Combination With Carboplatin for the Treatment of Recurrent Ovarian Cancer Choi CH11, Lee YY, Song TJ, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Gynecol Oncol. 2011 Mar;120(3):439-43. doi: 10.1016/j.ygyno.2010.11.022. Epub 2010 Dec 8. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA Lee YY11, Choi CH, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • J Cancer Res Clin Oncol. 2011 Mar;137(3):463-9. doi: 10.1007/s00432-010-0902-z. Epub 2010 May 13. Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma adenocarcinoma Choi CH11, Lee JS, Kim SR, Lee YY, Kim CJ, Lee JW, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2010 Dec;153(2):207-10. doi: 10.1016/j.ejogrb.2010.07.038. Epub 2010 Aug 21. Clinical significance of pmTOR expression in endometrioid endometrial carcinoma Choi CH11, Lee JS, Kim SR, Kim TJ, Lee JW, Kim BG, Bae DS.
    View PubMed
  • J Pediatr Surg. 2010 Oct;45(10):1955-60. doi: 10.1016/j.jpedsurg.2010.06.012. Pediatric borderline ovarian tumors: a retrospective analysis Song T11, Choi CH, Lee YY, Kim TJ, Lee JW, Bae DS, Kim BG.
    View PubMed
  • Int J Gynecol Cancer. 2010 Jul;20(5):798-803. Peritoneal Tuberculosis A Retrospective Review of 20 Cases and Comparison With Primary Peritoneal Carcinoma Choi CH11, Kim CJ, Lee YY, Kim JS, Song T, Park HS, Kim MK, Kim TJ, Lee JW, Lee JH, Bae DS, Kim BG.
    View PubMed
  • J Obstet Gynaecol Res. 2010 Apr;36(2):304-10. doi: 10.1111/j.1447-0756.2009.01131.x. Prognostic significance of p-STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy Choi CH11, Song SY, Kang H, Lee YY, Kim CJ, Lee JW, Kim TJ, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2010 Mar;116(3):459-63. doi: 10.1016/j.ygyno.2009.11.016. Epub 2009 Dec 8. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA) Lee YY11, Choi CH, Kim CJ, Song TJ, Kim MK, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • BMC Cancer. 2008 Oct 11;8:295. doi: 10.1186/1471-2407-8-295. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy Choi CH11, Song SY, Choi JJ, Park YA, Kang H, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Clin Cancer Res. 2008 May 1;14(9):2535-42. doi: 10.1158/1078-0432.CCR-07-1231. Altered MicroRNA expression in cervical carcinomas Lee JW11, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2008 May 1;71(1):199-204. Epub 2007 Nov 26. Prognostic value of baseline lymphocyte count in cervical carcinoma treated with concurrent chemoradiation Choi CH11, Kang H, Kim WY, Kim TJ, Lee JW, Huh SJ, Lee JH, Kim BG, Bae DS.
    View PubMed
  • Cancer Lett. 2007 Sep 18;255(1):26-33. Epub 2007 Apr 30. Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer Choi CH11, Lee KM, Choi JJ, Kim TJ, Kim WY, Lee JW, Lee SJ, Lee JH, Bae DS, Kim BG.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):817-22. Epub 2007 Mar 26. Phase II study of consolidation chemotherapy after concurrent chemoradiation in cervical cancer: Preliminary results Choi CH11, Lee JW, Kim TJ, Kim WY, Nam HR, Kim BG, Huh SJ, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2007 Jun;105(3):762-8. Epub 2007 Mar 26. Papillary serous carcinoma in ovaries of normal size: A clinicopathologic study of 20 cases and comparison with extraovarian peritoneal papillary serous carcinoma Choi CH11, Kim TJ, Kim WY, Ahn GH, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Gynecol Oncol. 2007 Jan;104(1):64-9. Epub 2006 Aug 10. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma Choi CH11, Kim TJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Eur J Obstet Gynecol Reprod Biol. 2006 Sep-Oct;128(1-2):243-7. Epub 2006 Feb 28. Expression of CD44 adhesion molecules on human placentae Choi CH11, Roh CR, Kim TJ, Choi YL, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed
  • Int J Gynecol Cancer. 2006 May-Jun;16(3):1157-64. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix Choi CH11, Kim TJ, Lee SJ, Lee JW, Kim BG, Lee JH, Bae DS.
    View PubMed